- Report
- March 2024
- 132 Pages
Global
From €843EUR$950USD£726GBP
- Report
- March 2024
- 132 Pages
Global
From €843EUR$950USD£726GBP
- Report
- March 2024
- 132 Pages
Global
From €843EUR$950USD£726GBP
- Report
- March 2024
- 132 Pages
Global
From €843EUR$950USD£726GBP
- Report
- December 2023
- 132 Pages
Global
From €843EUR$950USD£726GBP
- Report
- December 2023
- 132 Pages
Global
From €843EUR$950USD£726GBP
- Report
- December 2023
- 132 Pages
Global
From €843EUR$950USD£726GBP
- Report
- June 2023
- 132 Pages
Global
From €843EUR$950USD£726GBP
- Report
- March 2023
- 9 Pages
Global
From €2796EUR$3,150USD£2,406GBP
- Report
- December 2022
- 53 Pages
Global
From €3107EUR$3,500USD£2,674GBP
- Book
- June 2020
- 198 Pages
- Book
- September 2019
- 302 Pages
- Report
- April 2025
- 364 Pages
Global
From €2357EUR$2,655USD£2,028GBP
- Report
- November 2021
- 747 Pages
Global
From €3550EUR$4,000USD£3,056GBP
- Report
- March 2025
- 368 Pages
Global
From €2357EUR$2,655USD£2,028GBP
- Book
- November 2024
- 464 Pages
- Book
- August 2023
- 1360 Pages

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy.
The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more